BIOLINERX
Careers | Contact Us
search

Press Releases
March 28, 2019
BL-8040 and AGI-134 oncology programs progressing, with multiple data read-outs expected in the next 12 months

Management to hold conference call today, March 28, at 10:00 am EDT

March 27, 2019
Results presented as oral presentation at 45th Annual Meeting of European Society for Blood and Marrow Transplantation
March 21, 2019
Management to hold a conference call at 10:00 a.m. EDT
December 11, 2018
Results of triple combination arm of BL-8040, KEYTRUDA® and chemotherapy expected in H2 2019
November 20, 2018
Designation provides eligibility for 12 years of market exclusivity that complements robust IP estate

Phase 1/2a study ongoing with topline data expected by year-end 2020

1-10  Out of  306
 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15 
 16   17   18   19   20   21   22   23   24   25   26   27   28   29 
 30   31 
Next